Treatment of Microscopic Colitis

• Status: Terminated
• Trial end date: 2014-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The study compares the effect of Budesonide, Bismuth and fiber in patients with microscopic colitis

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Norwegian University of Science and Technology
• Collaborator: AstraZeneca
• Treatments: Bismuth; Budesonide

Criteria

Inclusion Criteria:

• Microscopic colitis verified with biopsies from the colon

• Symptoms to such an extent that treatment is indicated

• Age > 17 years

• Informed consent

Exclusion Criteria:

• Previous treatment with any of the investigational drugs

• Patients treated with ketoconazole

• Pregnant and breast-feeding females